Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

@article{Salley2007GlucoseII,
  title={Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.},
  author={Kelsey E. S. Salley and Edmond P. Wickham and Kai I Cheang and Paulina A. Essah and Nicole W. Karjane and John E. Nestler},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2007},
  volume={92 12},
  pages={
          4546-56
        }
}
OBJECTIVES Women with polycystic ovarian syndrome (PCOS) are at increased risk for developing glucose intolerance and type 2 diabetes mellitus (DM). Recommendations for the timing and method of screening have varied. The purpose of this statement is to determine the optimal screening method, timing of screening, and treatment modalities for impaired glucose tolerance (IGT) among women with PCOS. PARTICIPANTS The expert panel was appointed by the Androgen Excess Society (AES) to review the… 

Tables from this paper

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.
TLDR
A critical endocrine and European perspective on the debate on the definition of PCOS is offered and all major aspects related to aetiological factors, including early life events, potentially involved in the development of the disorder are summarized.
Use of metformin in polycystic ovary syndrome.
The polycystic ovary syndrome. A position statement from the European Society of Endocrinology
TLDR
A critical endocrine on the debate on the definition of PCOS and summarises all major aspects related to aetiological factors, including early life events, potentially involved in the development of the disorder.
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
TLDR
Evaluation of women with PCOS should exclude alternate androgen-excess disorders and risk factors for endometrial cancer, mood disorders, obstructive sleep apnea, diabetes, and cardiovascular disease.
Screening for Insulin Resistance in Polycystic Ovary Syndrome: Views of Physician Members of the American Society for Reproductive Medicine.
TLDR
Two-thirds of ASRM physician members surveyed screen women with PCOS for IR in spite of the lack of general consensus on the need for such screening from endocrine societies.
The polycystic ovary syndrome: a position statement from the European Society of
TLDR
A critical endocrine and European perspective on the debate on the definition of PCOS is offered and all major aspects related to aetiological factors, including early life events, potentially involved in the development of the disorder are summarized.
Polycystic ovary syndrome in adolescents
  • B. Rackow
  • Medicine, Biology
    Current opinion in obstetrics & gynecology
  • 2012
TLDR
As a better understanding of adolescent PCOS evolves, including appropriate diagnostic criteria, factors associated with concomitant metabolic disorders and effective treatment options, improved care for these adolescents will be achieved.
Insulin resistance and polycystic ovary syndrome.
Metabolic and androgen profile in underweight women with polycystic ovary syndrome
TLDR
Underweight in PCOS is associated with higher postprandial insulin levels, and several of underweight patients were able to achieve regular menstrual cycle under metformin therapy.
Metformin and Weight Loss in Patients with Polycystic Ovary Syndrome
TLDR
The use of high-dose metformin (>1500 mg per day) is associated with an average weight loss of 2.7 kg in 6 months; however, physical activity and diet were more efficient than met formin alone.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 82 REFERENCES
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
TLDR
It is the view of the AES Task Force on the Phenotype of PCOS that there should be acceptance of the original 1990 National Institutes of Health criteria with some modifications, taking into consideration the concerns expressed in the proceedings of the 2003 Rotterdam conference.
Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.
TLDR
The results indicate that adolescents with PCOS are at increased risk for IGT and DM and that the 2-h plasma glucose level after an oral glucose challenge appears to be the most reliable screening test for these abnormalities.
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
TLDR
It is concluded that women with PCOS should periodically have an OGTT and must be closely monitored for deterioration in glucose tolerance, particularly among those with IGT, the subgroup at highest risk for subsequent development of NIDDM.
Glucose intolerance in Japanese patients with polycystic ovary syndrome
TLDR
Japanese PCOS might have insulin-resistance but the factor of obesity had a stronger effect on insulin- Resistance than did the existence of PCOS.
Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
TLDR
All obese women with PCOS should be screened for the presence of insulin resistance by looking for other stigmata of the insulin resistance syndrome such as hypertension, dyslipidemia, central obesity, and glucose intolerance.
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.
TLDR
In conclusion, women with PCOS are at increased risk of pregnancy and neonatal complications and pre-pregnancy, antenatal and intrapartum care should be aimed at reducing these risks.
Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.
TLDR
Even though G:I, HOMA and QUICKI are easier than OGTT, they could not replace the role of 2-h post-challenge plasma glucose level in the screening of IGT and NIDDM in PCOS women.
Glucose intolerance in the polycystic ovary syndrome: role of the pancreatic beta-cell.
  • D. Ehrmann
  • Medicine, Biology
    Journal of pediatric endocrinology & metabolism : JPEM
  • 2000
TLDR
Identification of genetic factors and use of pharmacological agents may allow early identification of those women with PCOS who are at greatest risk for development of diabetes mellitus type 2.
Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome
TLDR
The aim of the study was to describe these risk factors in a population of Danish PCOS women attending a gynecologic clinic and to identify the parameters with the strongest correlation to the fasting blood glucose levels.
Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome
...
1
2
3
4
5
...